Literature DB >> 11112120

Sleep fragmentation, awake blood pressure, and sleep-disordered breathing in a population-based study.

M J Morrell1, L Finn, H Kim, P E Peppard, M S Badr, T Young.   

Abstract

Arousal from sleep produces transient increases in systemic blood pressure, leading to the suggestion that repeated arousals are associated with a sustained increase in daytime blood pressure. Using data from the Wisconsin Sleep Cohort Study, a population-based study, we tested the hypothesis that sleep fragmentation is associated with elevated awake blood pressure. Sleep, breathing, and seated blood pressure measurements from 1,021 participants (age 42 +/- 8 yr; 590 males) were analyzed. Sleep fragmentation was defined as the total number of awakenings and shifts to Stage 1 sleep divided by the total sleep time (sleep fragmentation index: SFI). To reduce the confounding influence of sleep-disordered breathing, which is related to both increased daytime blood pressure and sleep fragmentation, all participants with an apnea-hypopnea index (AHI) > or = 1 were analyzed separately. Accounting for the influences of sex, age, body mass index, and antihypertensive medication use, the SFI was significantly associated with higher levels of awake systolic blood pressure in people with an AHI < 1; a 2 standard deviation increase in the SFI was associated with a 3.1 mm Hg rise in awake systolic blood pressure. In participants with an AHI > or = 1, there was no independent association between the SFI and awake blood pressure after controlling for the influence of the AHI.

Entities:  

Mesh:

Year:  2000        PMID: 11112120     DOI: 10.1164/ajrccm.162.6.9904008

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  37 in total

Review 1.  Sleep apnoea and hypertension: proof at last?

Authors:  J R Stradling; J C Pepperell; R J Davies
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

2.  Mean tracheal sound energy during sleep is related to daytime blood pressure.

Authors:  Hiroshi Nakano; Kenji Hirayama; Yumiko Sadamitsu; Shizue Shin; Tomoaki Iwanaga
Journal:  Sleep       Date:  2013-09-01       Impact factor: 5.849

3.  Commentary on CPAP vs. oxygen for treatment of OSA.

Authors:  Shirin Shafazand; M Safwan Badr
Journal:  J Clin Sleep Med       Date:  2014-11-15       Impact factor: 4.062

4.  Back to basics regarding upper airway obstruction during sleep-size matters.

Authors:  M Safwan Badr
Journal:  Sleep       Date:  2014-06-01       Impact factor: 5.849

5.  Role of angiotensin-converting enzyme 1 within the median preoptic nucleus following chronic intermittent hypoxia.

Authors:  Katelynn Faulk; Brent Shell; T Prashant Nedungadi; J Thomas Cunningham
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-12-21       Impact factor: 3.619

Review 6.  Hypoxia-inducible factors and obstructive sleep apnea.

Authors:  Nanduri R Prabhakar; Ying-Jie Peng; Jayasri Nanduri
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

7.  Perspective on sleep and aging.

Authors:  Andrew A Monjan
Journal:  Front Neurol       Date:  2010-09-28       Impact factor: 4.003

8.  Plasma levels of retinoids, carotenoids and tocopherols in patients with mild obstructive sleep apnoea.

Authors:  Regina M Day; Ismael A Matus; Yuichiro J Suzuki; Kyung-Jin Yeum; Jian Qin; Ah-Mee Park; Vivek Jain; Tunay Kuru; Guangwen Tang
Journal:  Respirology       Date:  2009-09-16       Impact factor: 6.424

9.  Tolerance of chronic 90-minute time-in-bed restriction in older long sleepers.

Authors:  Shawn D Youngstedt; Christopher E Kline; Mark R Zielinski; Daniel F Kripke; Tina M Devlin; Richard K Bogan; Sara Wilcox; James W Hardin
Journal:  Sleep       Date:  2009-11       Impact factor: 5.849

10.  A state transition-based method for quantifying EEG sleep fragmentation.

Authors:  Vinayak Swarnkar; Udantha R Abeyratne; Craig Hukins; Brett Duce
Journal:  Med Biol Eng Comput       Date:  2009-08-25       Impact factor: 2.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.